HYFT (MindWalk Holdings) Altman Z2-Score: -17.19 (As of Jul. 01, 2026)


HYFT MindWalk Holdings Corp HYFT
38 GF Score
Price $1.63
GF Value $0.61
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is MindWalk Holdings Altman Z2-Score?

MindWalk Holdings HYFT +3.82% 38 Altman Z2-Score is -17.19 as of Jul. 01, 2026. GuruFocus rates HYFT with a GF Score™ of 38/100 and a GF Value™ of $0.61 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,394 Biotechnology companies, MindWalk Holdings ranks worse than 74.1% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Warning Sign:

MindWalk Holdings has a Altman Z2-Score of -17.19, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for MindWalk Holdings's Altman Z2-Score or its related term are showing as below:

HYFT' s Altman Z2-Score Range Over the Past 10 Years
Min: -2743.81   Med: -1.72   Max: 8.18
Current: -17.19

During the past 13 years, MindWalk Holdings's highest Altman Z2-Score was 8.18. The lowest was -2743.81. And the median was -1.72.


MindWalk Holdings  (NAS:HYFT) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


MindWalk Holdings Altman Z2-Score Related Terms


MindWalk Holdings Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for MindWalk Holdings's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MindWalk Holdings Altman Z2-Score Chart

MindWalk Holdings Annual Data
Trend Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.18 3.53 -1.53 -6.68 -11.87

MindWalk Holdings Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.05 -11.87 -11.59 -18.65 -17.19

HYFT vs ANVS, GANX, EXOZ: Altman Z2-Score Comparison

For the Biotechnology subindustry, MindWalk Holdings's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MindWalk Holdings Altman Z2-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindWalk Holdings's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where MindWalk Holdings's Altman Z2-Score falls into.


HYFT
38GF Score
MindWalk Holdings Corp HYFT
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MindWalk Holdings Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

MindWalk Holdings's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.5997+3.26*-6.0411+6.72*-0.4983+1.05*1.8284
=-17.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Jan. 2026:
Total Assets was $16.69 Mil.
Total Current Assets was $13.66 Mil.
Total Current Liabilities was $3.65 Mil.
Retained Earnings was $-100.84 Mil.
Pre-Tax Income was -2.867 + -2.283 + -3.052 + -0.106 = $-8.31 Mil.
Interest Expense was 0 + 0 + 0 + 0.01 = $0.01 Mil.
Total Liabilities was $5.90 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(13.663 - 3.653)/16.692
=0.5997

X2=Retained Earnings/Total Assets
=-100.838/16.692
=-6.0411

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-8.308 - 0.01)/16.692
=-0.4983

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(10.791 - 0)/5.902
=1.8284

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

MindWalk Holdings has a Altman Z2-Score of -17.19 indicating it is in Distress Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of -17.19 mean?
MindWalk Holdings (HYFT) has a Altman Z2-Score of -17.19 as of Jul. 01, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on MindWalk Holdings and its competitors. According to the industry distribution chart, MindWalk Holdings ranks #1033 out of 1394 companies in the Biotechnology industry, placing it in the top 74.1%.
Is MindWalk Holdings' Altman Z2-Score too high?
MindWalk Holdings' current Altman Z2-Score is -17.19. Based on the distribution chart, MindWalk Holdings ranks #1033 out of 1394 companies in the Biotechnology industry, which is below the industry midpoint. Overall, MindWalk Holdings has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MindWalk Holdings' Altman Z2-Score compare to ANVS and GANX?
According to the Biotechnology industry distribution chart, MindWalk Holdings ranks #1033 out of 1394 companies for Altman Z2-Score. This places MindWalk Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Biotechnology company?
A good Altman Z2-Score depends on the Biotechnology industry context. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on MindWalk Holdings and its competitors. MindWalk Holdings's current Altman Z2-Score is -17.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MindWalk Holdings stock overvalued right now?
Based on GuruFocus' analysis, MindWalk Holdings (HYFT) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.61, compared to a current price of $1.63 — trading 167.2% above its estimated fair value. The current Altman Z2-Score is -17.19. MindWalk Holdings' overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For MindWalk Holdings (HYFT), the current Altman Z2-Score is -17.19 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MindWalk Holdings (HYFT) Overvalued in 2026?

Based on GuruFocus' analysis, MindWalk Holdings stock appears to be overvalued. The current stock price of $1.63 is trading 167.2% above its estimated GF Value™ of $0.61. GuruFocus considers MindWalk Holdings to be Significantly Overvalued.

Key valuation signals for HYFT:

  • Altman Z2-Score: -17.19
  • GF Value™: $0.61 vs. price of $1.63 (167.2% above fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the HYFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MindWalk Holdings Business Description

Other Exchanges TQB0:Germany
Address Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
38GF Score

Get the complete analysis for HYFT

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.63
Price
$0.61
GF Value